A
RVMD icon

AlphaQuest’s Revolution Medicines RVMD Stock Holding History

AlphaQuest’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,664
Closed -$1.65M – 1678
2025
Q4 		$1.65M Buy
20,664
+8,751
+73% +$574K 0.09% 242
2025
Q3 		$556K Buy
11,913
+9,916
+497% +$388K 0.04% 726
2025
Q2 		$73.5K Buy
+1,997
New +$76.7K 0.01% 1524
2024
Q4 		– Sell
-18
Closed -$816 – 1970
2024
Q3 		$816 Hold
18
– – ﹤0.01% 1636
2024
Q2 		$699 Hold
18
– – ﹤0.01% 1379
2024
Q1 		$580 Buy
+18
New +$534 ﹤0.01% 1474

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AlphaQuest's RVMD Position: Q1 2026 in Review

AlphaQuest sold out of Revolution Medicines (RVMD) in Q1 2026, closing a stake of 20,664 shares — an estimated $1.65M sold.

AlphaQuest first reported a position in RVMD in Q1 2024 and held it in 6 quarters. The position peaked at $1.65M in Q4 2025. 514 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • AlphaQuest reported no remaining Revolution Medicines position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 20,664 Revolution Medicines shares in Q1 2026, an estimated $1.65M.
  • AlphaQuest first reported a position in Revolution Medicines in Q1 2024 and held it in 6 quarters.
  • AlphaQuest's Revolution Medicines position peaked at $1.65M in Q4 2025.
  • 514 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.